|Title:||Dilemmas in the Compassionate Supply of Investigational Cancer Drugs|
|Citation:||Lewis J, Lipworth W, Doran E, Kerridge I. Dilemmas in the Compassionate Supply of Investigational Cancer Drugs. Internal Medicine Journal. Published online 10 Sept 2014. 44 (2014). doi:10.1111/imj.12530|
|Abstract:||In Australia, patients who want to access medicines that are not yet approved have only two options: to enrol in a clinical trial if they are eligible, or obtain their medicine through ‘compassionate supply’, which is provided at the discretion of the manufacturer. In this article, we explore ethical issues associated with the provision of oncology medicines that are still in development, either prior to regulatory approval or government reimbursement. Keywords: ethics; evidence-based medicine; health services accessibility; oncology|
|Type of Work:||Article|
|Appears in Collections:||Research Papers and Publications. Sydney Health Ethics|
|dilemmas-in-the-compassionate-supply-PP2014.pdf||403.77 kB||Adobe PDF|
Items in Sydney eScholarship Repository are protected by copyright, with all rights reserved, unless otherwise indicated.